Symbol Name ID |
Mir141
microRNA 141 MGI:2676826 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Badtm1Sjk/Badtm1Sjk Tg(Ins2-Mirc13)E4Biat/0 involves: 129X1/SvJ * C57BL/6N |
hyperglycemia | J:314874 |
Baxtm1Sjk/Baxtm1Sjk Tg(Ins2-Mirc13)E4Biat/0 involves: 129X1/SvJ * C57BL/6N |
normal endocrine/exocrine gland phenotype | J:314874 |
normal homeostasis/metabolism phenotype | J:314874 | |
Tg(Ins2-Mirc13)E4Biat/0 C57BL/6N-Tg(Ins2-Mirc13)E4Biat |
decreased body fat mass | J:314874 |
decreased circulating insulin level | J:314874 | |
decreased insulin secretion | J:314874 | |
decreased pancreatic beta cell mass | J:314874 | |
hyperglycemia | J:314874 | |
increased pancreatic beta cell apoptosis | J:314874 | |
ketoacidosis | J:314874 | |
Tg(Ins2-Mirc13)E4Biat/0 Tg(RIP1-Tag)2Dh/0 involves: C57BL/6J * C57BL/6N * DBA/2J |
normal endocrine/exocrine gland phenotype | J:314874 |
normal homeostasis/metabolism phenotype | J:314874 | |
Trp53tm1Tyj/Trp53+ Tg(Ins2-Mirc13)E4Biat/0 involves: 129S2/SvPas * C57BL/6N |
normal homeostasis/metabolism phenotype | J:314874 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|